1 August 2018 in International Journal of Pharmaceutics
HLHarivardhan Reddy Lakkireddy
Harivardhan Reddy Lakkireddy
1 December 2014 in International Journal of Pharmaceutics
20 May 2019 in Pharmaceutical Development and Technology
Jet milling is frequently used in pharmaceutical industry to achieve different objectives. It can be used as enabling technology to overcome poor water solubility linked to hydrophobic active of pharmaceutical ingredient (API) by reducing the particle size and therefore the dissolution rate. Alternatively jet milling can be used either to enhance blending efficiency of API with excipient in case of formulation at low dosage strength or to achieve the required particle size for inhalation therapy. In this study, development of commercial manufacturing process of sticky API and its industrialization are described. The methodology used is based on quality-by-design (QbD) approach to deliver safe, effective and robust manufacturing process. The study showed that the specific energy is a key factor that drives particle size during jet milling and the scale-up from lab to industrial scale. After understanding the process, a design space was built where different zones such as operating point, operating space (where the product is compliant to specification despite variability of process parameters) and the knowledge space were outlined. Finally, an industrial installation was proposed to deliver product with high productivity yield, compliant with safety regulation and cleanable in place.
1 July 2017 in Journal of Pharmaceutical Sciences
1 July 2023 in Journal of Pharmaceutical Sciences
1 June 2016 in International Journal of Pharmaceutics